Le Lézard
Classified in: Health
Subject: PER

UPMC Center for High-Value Health Care Names Dr. Chester "Bernie" Good Senior Medical Director for the Center for Value-Based Pharmacy Initiatives


PITTSBURGH, Jan. 23, 2018 /PRNewswire/ -- Dr. Chester "Bernie" Good has been named senior medical director for the Center for Value-Based Pharmacy Initiatives (VBPI), which is housed within the UPMC Center for High-Value Health Care.

 (PRNewsfoto/UPMC Health Plan)

The Center for Value-Based Pharmacy Initiatives (VBPI), which is supported jointly by UPMC Health Plan and a research grant from Express Scripts, was launched in 2017 to leverage the unique assets and resources of the UPMC Insurance Services Division to develop, implement, and evaluate new value-based payment models for pharmaceuticals at UPMC.

In his new role as senior medical director, Dr. Good will provide leadership and direction for VBPI research projects, collaborations, and dissemination activities and will support related research objectives of UPMC's Center for High-Value Health Care, the Health Plan's not-for-profit research group.

"Bernie brings more than 30 years of experience, including leadership roles at the University of Pittsburgh's school of medicine and school of pharmacy and at the Department of Veterans Affairs, where he served as the medical advisory panel for VA Pharmacy Benefits Management chairperson," said Chronis Manolis, RPh, chief pharmacy officer at UPMC Health Plan. "Bernie will spearhead the Center for Value-Based Pharmacy Initiatives' efforts to include value assessments to address the rising cost of medications, which is a central policy issue and a major driver of increasing healthcare costs."

Dr. Good will be responsible for developing innovative, value-based alternative payment models. He will also identify and track trends toward alternative, value-based purchasing of drugs and other innovations in pharmacy strategy.

In addition to his role with the VBPI, Dr. Good will continue to serve as a faculty member at the University of Pittsburgh's school of medicine and school of pharmacy.

He earned his bachelor's degree in biochemistry from the University of Maryland, his medical degree from George Washington University, and his master of public health degree in epidemiology from the University of Pittsburgh. He is widely published, with research interests in drug safety and effectiveness, and conflicts of interest in medicine.

About the UPMC Insurance Services Division

The UPMC Insurance Services Division is owned by UPMC (University of Pittsburgh Medical Center) a world-renowned health care provider and insurer based in Pittsburgh, Pa. The UPMC Insurance Services Division ? which includes UPMC Health Plan, WorkPartners, UPMC for Life, UPMC for You, UPMC for Kids, and Community Care Behavioral Health ? offers a full range of group health insurance, Medicare, Special Needs, CHIP, Medical Assistance, behavioral health, employee assistance and workers' compensation products and services to more than 3.2 million members. For more information, visit www.upmchealthplan.com.

SOURCE UPMC Health Plan


These press releases may also interest you

at 09:10
BioSkryb Genomics, a company ushering in the next generation of single-cell technology, will highlight how its ResolveDNA and ResolveOME single-cell assays can unravel the complexities of tumor evolution at the American Association for Cancer...

at 09:07
KURU® Footwear, the inventor of heel-first footwear, today unveiled its 2024 Foot Pain Trends Report. Featuring significant industry discoveries and valuable consumer perspectives, KURU's comprehensive and medically reviewed report highlights the...

at 09:05
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...

at 09:05
...

at 09:04
Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation's total grant funding to Noze to $1.8 million. The announcement comes...

at 09:00
Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse...



News published on and distributed by: